Recommendations on biomarker bioanalytical method validation by GCC

Area of Science:

• Biopharmaceutical Development
• Analytical Chemistry
• Clinical Research Operations

Background:

• Biomarker bioanalytical method validation is critical for drug development.
• Standardization of validation practices is needed across Contract Research Organizations (CROs).
• Previous discussions have highlighted variability in current validation approaches.

Purpose of the Study:

• To consolidate opinions and perspectives from CRO leaders on biomarker bioanalytical method validation.
• To reach consensus on key recommendations for improving validation practices.
• To foster harmonization in bioanalytical method validation across the industry.

Main Methods:

• The study involved discussions and consensus-building among leaders from Contract Research Organizations (CROs).
• Data was gathered through open sharing of opinions and perspectives at two Global CRO Council (GCC) events.
• Recommendations were developed based on collective agreement during these meetings.

Main Results:

• Agreement was reached on several key recommendations for biomarker bioanalytical method validation.
• Identified areas of consensus include critical aspects of method validation.
• The discussions facilitated a shared understanding of best practices among CRO leaders.

Conclusions:

• The GCC events successfully brought together CRO leaders to address critical issues in bioanalytical method validation.
• Consensus on recommendations is expected to drive standardization and enhance the quality of biomarker data.
• These agreed-upon recommendations will serve as a valuable guide for the biopharmaceutical industry.